Recombinant Cytokeratin 19 antibody
Quick Overview for Recombinant Cytokeratin 19 antibody (ABIN7861587)
Target
See all Cytokeratin 19 (KRT19) AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- Recombinant Cytokeratin 19 (Pancreatic Stem Cell Marker) Antibody
-
Specificity
- Recognizes a protein of 40 kDa, identified as cytokeratin-19 (CK19), which is expressed in sweat gland, mammary gland ductal and secretory cells, bile ducts, gastrointestinal tract, bladder urothelium, oral epithelia, esophagus, and ectocervical epithelium. Anti-CK19 reacts with a wide variety of epithelial malignancies including adenocarcinomas of the colon, stomach, pancreas, biliary tract, liver, and breast. Perhaps the most useful application is the identification of thyroid carcinoma of the papillary type, although 50 % -60 % of follicular carcinomas are also labeled. Anti-CK19 is a useful marker for detection of tumor cells in lymph nodes, peripheral blood, bone marrow and breast cancer.
-
Purification
- 200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.
-
Immunogen
- Recombinant full-length human KRT19 protein.
-
Isotype
- IgG2b, kappa
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- Prepared in 10 mM PBS
-
Preservative
- Azide free
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
-
-
- Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
-
Alternative Name
- Cytokeratin 19
-
Background
-
k19, k1cs, Keratin 19 Keratin Type i 40kD, KRT19
MCF-7 or HeLa cells. Breast cancer tissues. Skin.
-
Molecular Weight
- 40kDa
-
Gene ID
- 3880, 654568
-
UniProt
- P08727
Target
-